Brasko, Csilla
Smith, Kevin
Molnar, Csaba
Farago, Nora
Hegedus, Lili
Balind, Arpad
Balassa, Tamas
Szkalisity, Abel
Sukosd, Farkas
Kocsis, Katalin
Balint, Balazs http://orcid.org/0000-0002-5102-0787
Paavolainen, Lassi
Enyedi, Marton Z.
Nagy, Istvan http://orcid.org/0000-0003-2528-9173
Puskas, Laszlo G.
Haracska, Lajos
Tamas, Gabor
Horvath, Peter
Article History
Received: 1 January 2017
Accepted: 14 December 2017
First Online: 15 January 2018
Competing interests
: P.H. is the founder and shareholder of Single-cell technologies Ltd.; L.G.P. is the founder and shareholder of Avidin Ltd. that provided SingleCellProtect reagent; B.B. and I.N. had consulting positions at SeqOmics Biotechnology Ltd. at the time the study was conceived. Single-cell technologies Ltd., Avidin Ltd., and Seqomics Biotechnology Ltd. were not directly involved in the design and execution of the experiments or in the writing of the manuscript. This does not alter the author’s adherence to all the <i>Nature</i> policies on sharing data and materials. The remaining authors declare no competing financial interests.